Mechanism of the allosteric activation of the ClpP protease machinery by substrates and active-site inhibitors.

Clicks: 238
ID: 54625
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Coordinated conformational transitions in oligomeric enzymatic complexes modulate function in response to substrates and play a crucial role in enzyme inhibition and activation. Caseinolytic protease (ClpP) is a tetradecameric complex, which has emerged as a drug target against multiple pathogenic bacteria. Activation of different ClpPs by inhibitors has been independently reported from drug development efforts, but no rationale for inhibitor-induced activation has been hitherto proposed. Using an integrated approach that includes x-ray crystallography, solid- and solution-state nuclear magnetic resonance, molecular dynamics simulations, and isothermal titration calorimetry, we show that the proteasome inhibitor bortezomib binds to the ClpP active-site serine, mimicking a peptide substrate, and induces a concerted allosteric activation of the complex. The bortezomib-activated conformation also exhibits a higher affinity for its cognate unfoldase ClpX. We propose a universal allosteric mechanism, where substrate binding to a single subunit locks ClpP into an active conformation optimized for chaperone association and protein processive degradation.
Reference Key
felix2019mechanismscience Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Felix, Jan;Weinhäupl, Katharina;Chipot, Christophe;Dehez, François;Hessel, Audrey;Gauto, Diego F;Morlot, Cecile;Abian, Olga;Gutsche, Irina;Velazquez-Campoy, Adrian;Schanda, Paul;Fraga, Hugo;
Journal Science advances
Year 2019
DOI 10.1126/sciadv.aaw3818
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.